Ghulam Khaleel, MD
Clinical Neurophysiology · White Hall, ARNPI 1669486007
Payments from drug & device makers
Across 619 payments — averaging $20.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$2K
- Novartis$1K
- Biogen$1K
- SK Life Science, Inc.$930
- UCB, Inc.$788
- Supernus Pharmaceuticals, Inc.$679
- plus $6K from 40 others
What the payments were for
- Speaking & faculty fees$340%
- Travel & lodging$1,35311%
- Food & beverage$11,30289%
- Education$30%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,683
- REXULTI$124
- AIMOVIG$107
How this compares
Too few clinical neurophysiology providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 26 | $460,433 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 26 | $366,105 |
| VumerityDiroximel Fumarate | 20 | $173,222 |
| TysabriNatalizumab | 12 | $95,569 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,877 | $66,038 |
| AptiomEslicarbazepine Acetate | 40 | $52,821 |
| Aimovig AutoinjectorErenumab-Aooe | 27 | $30,626 |
| Nurtec OdtRimegepant Sulfate | 16 | $29,688 |
| ValtocoDiazepam | 34 | $29,130 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 704 | $27,480 |
| XcopriCenobamate | 17 | $19,868 |
| EliquisApixaban | 22 | $19,597 |
| Emgality PenGalcanezumab-Gnlm | 12 | $18,955 |
| NamzaricMemantine Hcl/Donepezil Hcl | 13 | $17,330 |
| RytaryCarbidopa/Levodopa | 35 | $16,409 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerOctagam, Nurtec Odt, Eliquis | $73 | $415,39164 claims |
| BiogenVumerity, Tysabri | $1,045 | $268,79132 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $502 | $52,82140 claims |
| AbbVieNamzaric, Ubrelvy | $678 | $31,56624 claims |
| Neurelis, Inc.Valtoco | $454 | $29,13034 claims |
| UCB, Inc.Nayzilam, Neupro | $788 | $24,68529 claims |
| SK Life Science, Inc.Xcopri | $930 | $19,86817 claims |
| Amneal Pharmaceuticals LLCRytary | $481 | $16,40935 claims |
| Upsher-smith Laboratories LLCTopiramate | $39 | $1,470206 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical neurophysiology providers in Arkansason file to place this against a meaningful peer group, so we don't.
Other clinical neurophysiology in White Hall
- Victor BitonLittle Rock$677K
- Sudhakar TummalaLittle Rock$5K
- Barbara BessRogers$20
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.